The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307*
- From the Howard Hughes Medical Institute, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215 and ¶Howard Hughes Medical Institute, Department of Molecular Medicine, University of Massachusetts, Worcester, Massachusetts 01605
Abstract
Tumor necrosis factor α (TNFα) inhibits insulin action, in part, through serine phosphorylation of IRS proteins; however, the phosphorylation sites that mediate the inhibition are unknown. TNFα promotes multipotential signal transduction cascades, including the activation of the Jun NH2-terminal kinase (JNK). Endogenous JNK associates with IRS-1 in Chinese hamster ovary cells. Anisomycin, a strong activator of JNK in these cells, stimulates the activity of JNK bound to IRS-1 and inhibits the insulin-stimulated tyrosine phosphorylation of IRS-1. Serine 307 is a major site of JNK phosphorylation in IRS-1. Mutation of serine 307 to alanine eliminates phosphorylation of IRS-1 by JNK and abrogates the inhibitory effect of TNFα on insulin-stimulated tyrosine phosphorylation of IRS-1. These results suggest that phosphorylation of serine 307 might mediate, at least partially, the inhibitory effect of proinflammatory cytokines like TNFα on IRS-1 function.
- IRS
- insulin receptor substrate
- JNK
- c-Jun NH2-terminal kinase
- MAP
- mitogen-activated protein
- MAPKK
- MAP kinase kinase
- MAPKKK
- MAPKK kinase
- TNFα
- tumor necrosis factor
- CHO
- Chinese hamster ovary
- PAGE
- polyacrylamide gel electrophoresis
- GST
- glutathione S-transferase
- HPLC
- high pressure liquid chromatography
- PI
- phosphatidylinositol
- JIP
- JNK-interacting protein
- JBD
- JNK-binding domain
- IVK
- in vitro kinase
- IP
- immunoprecipitate(s)
- PTB
- phosphotyrosine binding domain
- Received December 6, 1999.
- The American Society for Biochemistry and Molecular Biology, Inc.











